Quantcast

Latest Anastrozole Stories

2009-09-28 15:26:00

Estrogen levels following menopause may impact risk of joint pain caused by drugs; electro-acupuncture proves helpful for alleviating symptoms Aromatase inhibitors, the same drugs that have buoyed long-term survival rates among breast cancer patients, also carry side effects including joint pain so severe that many patients discontinue these lifesaving medicines. New University of Pennsylvania School of Medicine research, however, has uncovered patterns that may help clinicians identify and...

2009-09-22 07:57:47

New research has found that switching post-menopausal women with early breast cancer to the drug exemestane (Aromasin) after two or three years of tamoxifen rather than keeping them on tamoxifen for five years improves the chance of remaining cancer free and reduces the risk of death for at least the next six years. "These findings have confirmed that the strategy of switching to exemestane mid-way through the five-year tamoxifen treatment plan provides a clear and durable benefit for relapse...

2009-05-30 14:45:00

Popular antidepressants taken with tamoxifen can increase the risk of breast cancer recurrence PHILADELPHIA, May 30 /PRNewswire-USNewswire/ -- A new study found that taking tamoxifen with certain antidepressants more than doubled the risk of breast cancer recurrence in women taking both medications. The antidepressants inhibit an enzyme, CYP2D6, which helps tamoxifen work effectively. (Logo: http://www.newscom.com/cgi-bin/prnh/20090530/DC24767LOGO) The study was conducted by...

2008-12-15 23:22:32

Aromatase inhibitors, which lower the amount of estrogen in the body, are more effective in preventing breast cancer than tamoxifen, U.S. researchers said. Two separate meta-analyses of worldwide clinical trials tested tamoxifen against aromatase inhibitor drugs in post-menopausal women with early breast cancer, and each reached the same conclusion: aromatase inhibitors are more effective in preventing breast cancer from coming back. Tamoxifen and aromatase inhibitors are widely used to...

2008-12-14 07:00:00

SAN DIEGO, Dec. 14 /PRNewswire/ -- bioTheranostics, a bioMerieux company that discovers, develops and commercializes new molecular diagnostic tests in oncology, reported today findings from three studies using the company's molecular breast cancer assay to predict risk of disease recurrence in individual patients. Data from the studies were presented this week at the San Antonio Breast Cancer Symposium (SABCS). The Theros Breast Cancer Index(SM) (BCI) is a combination of Theros...

2008-12-13 10:00:00

SAN ANTONIO, Dec. 13 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced findings from a European study demonstrating that the Oncotype DX Recurrence Score(R) result is a significant independent predictor of distant recurrence in both node-negative and node-positive, hormone receptor-positive breast cancer patients who are treated with the aromatase inhibitor anastrozole or with tamoxifen. Researchers from the Royal Marsden Hospital in London discussed results...

a03f5ca8c210a9eba8e1475d7db1e5901
2008-11-20 12:22:15

Cancer drugs aren't the only culprits Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss. But a new study has found that cancer drugs aren't the only culprits. Among 64 breast cancer patients referred to a bone health clinic, 78 percent had at least one other cause of bone loss, including vitamin D deficiency, excessive calcium excretion in urine and an overactive parathyroid gland. "Doctors evaluating breast...

a171770fc779d62de5c3fb063c6fa3841
2008-11-13 08:49:02

Scientists in the UK published a study on Wednesday claiming they have figured out why some women develop resistance to the most commonly used breast cancer drug, something that raises the risk their tumors will return. Jason Carroll of Cancer Research UK in Cambridge, who led the study published in the journal Nature, said the findings could lead to new tests to determine which women are not likely to benefit from tamoxifen and who should be given other drugs. Carroll said the information...

2008-10-14 06:00:16

By Lyndsay Moss A MAJOR medical trial that could lead to the prevention of thousands of cases of breast cancer every year has been jeopardised by a shortage of Scottish women volunteers. The worldwide study - IBIS II - is investigating whether a drug called anastrozole could be used to prevent breast cancer in women at high risk of the disease. But despite a campaign to recruit women to take part in the trial, after four years just 68 volunteers in Scotland have come forward - well...

2008-09-06 21:00:04

Many breast cancers are made worse by the hormone oestrogen and women take drugs known as aromatase inhibitors to reduce the oestrogen in their body and restrict the cancer's progress. But eventually the tumour becomes resistant to this treatment and starts to grow.Now American researchers said a drug called sorafenib may be able to reverse this process."At first, the tumour's growth is halted because the aromatase inhibitor is depriving the cancer of the oestrogen it needs to grow," says...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related